Pregnancy Clinical Trial
Official title:
Detection of Sleep Apnea Syndrome (OSA) With Watch PAT 200 in Pregnant Women and Assessment of Impact of OSA on Intra-uterine Fetal Growth and Maternal Well-being
To assess prevalence of obstructive sleep apnea during pregnancy and its impact on prgnancy course and materno foetal wellbeing.
During pregnancy, obstructive sleep apnea (OSA) prevalence is estimated between 5% and 15%
and is associated with maternal and fetal comorbidities such as preeclampsia, neonatal
intensive care admission , fetal growth retardation , preterm birth but even if growing,
literature is still relatively poor about this topic.
To date, there is no systematic screening of OSA performed in at-risk pregnant women
(obesity, hypertension, diabetes, fetal growth retardation, suggestive symptoms), probably
mainly because of polysomnography complexity and accessibility.
As in non pregnant woman, OSA must be treated adequately during pregnancy. Continuous
positive airway pressure (CPAP) is the reference treatment for severe OSA. This device, by
blowing air under pressure in upper airways, via a nasal of an oro-nasal mask, is able to
alleviate the upper airway collapse responsible for the occurrence of obstructive sleep
apnea. It has been proven to offer a survival benefit in patients with severe disease and to
improve sleep quality, cardiovascular variables and health-related quality of life . CPAP
have been shown to improve fetal well-being in pre-eclampsia .
Oral appliance can be an alternative for mild to moderate disease and in patients who do not
tolerate CPAP. Positional counselling can be sufficient in case of mild to moderate
positional OSA. Associated behavioural strategies (diet and exercise) are always recommended
in case of excessive weight. Surgical treatments are dedicated to patients with specific
anatomic problems but cannot be performed during pregancy.
Aim of the study:
The primary aim of this study is to screen OSA in at risk pregnant women with Watch-PAT 200,
a simplified sleep study tool used on ambulatory mode and able to detect accurately OSA in
suspected patients. As secondary aim, we will observe the impact of OSA on a composite
endpoint assessing materno-fetal wellbeing.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02520687 -
Effects of Dietary Nitrate in Hypertensive Pregnant Women
|
Phase 1 |